CONTEXT: The failure and complications of central venous access devices (CVADs) result
in interrupted medical treatment, morbidity, and mortality for the patient. The resulting …

The objective of this review was to determine whether consistent definitions were used in
published studies of bloodstream infections due to central venous catheters in patients with …

BACKGROUND: Totally Implantable Venous Access Port Systems (TIVAPS) are widely used
in oncology, but complications are frequent, sometimes necessitating device removal and …

Background Although several studies have estimated the attributable cost and length of stay
(LOS) of central line–associated bloodstream infections (CLABSIs) in the pediatric intensive …

Totally implantable venous access port systems (TIVAPS) are widely used in breast cancer
patients. However, complications are frequent and may necessitate device replacement or …

Central venous catheters (CVCs) are essential in the management of pediatric patients
receiving antineoplastic therapy or bone marrow transplants, and have significantly …

Objective We aimed to study factors associated with the outcome of totally implantable
venous-access port (TIVAP)-related infections. Patients and methods We conducted a …

To test the efficacy and safety of corticotropin-based immunotherapies in pediatric
opsoclonus-myoclonus syndrome, 74 children received corticotropin alone or with …

BACKGROUND: The objective of this study was to determine whether severe neutropenia
on the day of port‐a‐catheter (PORT) insertion was a risk factor for catheter‐associated …

Objective: To evaluate the impact of prophylactic antibiotics on early infectious complications
after central venous access device (VAD) placement in children with cancer. Summary of …